It is particularly worth noting that the decreased expression of E2F1 in asthma patients is consistent with what we have previously observed in COPD patients (Du et al., 2019), which is different from that in lung cancer patients (Tsai et al., 2019). This evidence concerns the gene E2F1 and lung carcinoma.